🔥🐔 BizChicken 🐔🔥
Companies Similar to ArriVent BioPharma, Inc. Common Stock
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Telomir Pharmaceuticals, Inc. Common Stock
TELOMIR-1
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on developing and commercializing therapies for age-related inflammatory conditions and post-chemotherapy recovery.
Symbol: TELO
Recent Price: $4.64
Industry: Biotechnology
CEO: Mr. Erez Aminov
Sector: Healthcare
Employees: 1
Address: 855 N Wolfe Street, Baltimore, null 21205
Phone: (737)-289-0835
Last updated: 2024-12-31
Ardelyx, Inc.
tenapanor
Ardelyx, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for gastrointestinal and cardiorenal therapeutic areas, including treatments for irritable bowel syndrome with constipation and hyperphosphatemia.
About | Vision/Values | Leadership | About | About | About | About | Contact | About | About | About
Symbol: ARDX
Recent Price: $5.25
Industry: Biotechnology
CEO: Mr. Michael G. Raab
Sector: Healthcare
Employees: 267
Address: 400 Fifth Avenue, Waltham, MA 02451
Phone: 510 745 1700
Leadership
- Justin Renz, Chief Financial & Operations Officer
- Eric Foster, Chief Commercial Officer
- Elizabeth Grammer, Esq., Chief Legal & Administrative Officer
- Laura Williams, MD MPH, Chief Medical Officer
- Robert Blanks, MS RAC, Chief Regulatory Affairs & Quality Assurance Officer
- David Rosenbaum, PhD, Chief Development Officer
- Mike Kelliher, Executive Vice President, Corporate Development and Strategy
- Charon Spencer, Chief Human Resources Officer
- David Mott, Chairman
- Robert Bazemore, Director
- William A. Bertrand, Jr., JD, Director
- Muna Bhanji, R.Ph, Director
- Onaiza Cadoret-Manier, Director
- Mike Raab, Director
- Richard Rodgers, Director
Last updated: 2024-12-31
Arvinas, Inc.
Bavdegalutamide, ARV-471, ARV-766
Arvinas, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company is based in New Haven, Connecticut and collaborates with organizations like Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG.
About | Leadership | Contact | Culture | Culture | Culture | About | News | Events | ESG | About | About | About | About | About | About | About | About | About | About | About | About | Events | ESG | About | About | About | About | About | About | About | Culture | Culture | Vision/Values | Culture | Careers | About | About | About | About | News | About | About | Contact | About | About
Symbol: ARVN
Recent Price: $19.00
Industry: Biotechnology
CEO: Dr. John G. Houston Ph.D.
Sector: Healthcare
Employees: 445
Address: 5 Science Park, New Haven, CT 06511
Phone: 203 535 1456
Leadership
- John G. Houston, Ph.D., Chairperson, Chief Executive Officer, and President
- Noah Berkowitz, M.D., Ph.D., Chief Medical Officer
- Angela M. Cacace, Ph.D., Chief Scientific Officer
- Jared Freedberg, J.D., General Counsel and Corporate Secretary
- Paul McInulty, Senior Vice President, Regulatory Affairs
- John Northcott, Chief Commercial Officer
- Kelly Page, Senior Vice President, Global Head of Oncology Strategy and Program Leadership
- Andrew Saik, Chief Financial Officer
- Lisa Sinclair, Senior Vice President, Corporate Operations
- Ian Taylor, Ph.D., President, R&D
- Randy Teel, Ph.D., Chief Business Officer
- Steve Weiss, Senior Vice President, Chief Human Resources Officer
Last updated: 2024-12-31
ArriVent BioPharma, Inc. Common Stock
Furmonertinib
Arri Vent Bio Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing medicines for unmet medical needs in cancer, particularly NSCLC and other solid tumors. It develops Furmonertinib, a selective tyrosine kinase inhibitor. The company is based in Newtown Square, Pennsylvania and has strategic partnerships for advancing its pipeline.
Symbol: AVBP
Recent Price: $26.95
Industry: Biotechnology
CEO: Dr. Zhengbin Yao Ph.D.
Sector: Healthcare
Employees: 40
Address: 18 Campus Boulevard, Newtown Square, null 19073
Phone: 628-277-4836
Last updated: 2024-12-31
BioMarin Pharmaceutical Inc.
Vimizim
Bio Marin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Their products cater to conditions like mucopolysaccharidosis, phenylketonuria, Batten disease, and more.
About | Leadership | Directors | About | About | About | Locations | Contact | About | Careers | Careers | Benefits | Careers | Events | Careers | Careers | Careers | Careers | Careers | Careers | Locations | Careers | Careers | Careers | Careers | Jobs | Site Map | About | About | About | About | About | About | About | About
Symbol: BMRN
Recent Price: $65.45
Industry: Biotechnology
CEO: Mr. Alexander Hardy
Sector: Healthcare
Employees: 3401
Address: 770 Lindaro Street, San Rafael, CA 94901
Phone: 415 506 6700
Leadership
- Mark Enyedy,
- Alexander Hardy,
- Elaine J. Heron,
- G. Eric Davis, Executive Vice President, Chief Legal Officer
- Greg Friberg, Executive Vice President, Chief Research & Development Officer
- C. Greg Guyer, Executive Vice President, Chief Technical Officer
- Cristin Hubbard, Executive Vice President, Chief Commercial Officer
- Marni Kottle, Executive Vice President, Chief Corporate Affairs Officer
- Brian R. Mueller, Executive Vice President, Chief Financial Officer
- James Sabry, Executive Vice President, Chief Business Officer
- Amy Wireman, Executive Vice President, Chief People Officer
- Richard A. Meier,
- Elizabeth McKee Anderson,
- Barbara Bodem,
- Athena Countouriotis,
- Willard H. Dere,
- Maykin Ho,
- Robert J. Hombach,
- David E.I. Pyott,
Last updated: 2024-12-31
Curis, Inc.
Emavusertib
Curis, Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers, with a range of clinical stage and pipeline products targeting lymphomas, leukemia, and solid tumors.
About | Management | Directors | About | About | Contact | Contact | Contact | About | Careers | Careers | Benefits | About | About | About | About | Jobs | About
Symbol: CRIS
Recent Price: $3.14
Industry: Biotechnology
CEO: Mr. James E. Dentzer
Sector: Healthcare
Employees: 49
Address: Building C, Lexington, MA 02421
Phone: 617 503 6500
Leadership
- Martyn D. Greenacre, Chair of the Board
- John Hohneker, M.D., Director
- Kenneth I. Kaitin, Ph.D., Director
- Anne E. Borgman, M.D., Director
- Marc Rubin, M.D., Director
- James Dentzer, Chief Executive Officer and Director
Last updated: 2024-12-31
Corvus Pharmaceuticals, Inc.
Mupadolimab (CPI-006)
Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing immuno-oncology therapies, including Mupadolimab for non-small cell lung cancer, CPI-818 for T-cell lymphomas, and Ciforadenant for renal cell cancer.
Symbol: CRVS
Recent Price: $5.25
Industry: Biotechnology
CEO: Dr. Richard A. Miller M.D.
Sector: Healthcare
Employees: 28
Address: 863 Mitten Road, Burlingame, CA 94010
Phone: 650 900 4520
Last updated: 2024-12-31
Eton Pharmaceuticals, Inc.
Biorphen, Carglumic Acid, Rezipres, Alkindi Sprinkle, EPRONTIA, Alaway Preservative Free
Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for rare diseases, with a portfolio including treatments like Biorphen, Carglumic Acid, and others for various indications.
Symbol: ETON
Recent Price: $13.03
Industry: Biotechnology
CEO: Mr. Sean E. Brynjelsen
Sector: Healthcare
Employees: 30
Address: 21925 West Field Parkway, Deer Park, IL 60010-7208
Phone: 847 787 7361
Last updated: 2024-12-31
FibroGen, Inc.
Roxadustat, Pamrevlumab
Fibro Gen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics to treat serious unmet medical needs, including treatments for anemia, idiopathic pulmonary fibrosis, and Duchenne muscular dystrophy.
Symbol: FGEN
Recent Price: $0.53
Industry: Biotechnology
CEO: Mr. Thane Wettig
Sector: Healthcare
Employees: 486
Address: 409 Illinois Street, San Francisco, CA 94158
Phone: 415 978 1200
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
Mirum Pharmaceuticals, Inc.
LIVMARLI
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for rare and orphan diseases, with products like LIVMARLI and Volixibat.
Symbol: MIRM
Recent Price: $41.18
Industry: Biotechnology
CEO: Mr. Christopher Peetz
Sector: Healthcare
Employees: 294
Address: 950 Tower Lane, Foster City, CA 94404
Phone: 650 667 4085
Leadership
- Chris Peetz, Chief Executive Officer, Mirum Pharmaceuticals
- Erin Campany, Senior Vice President, Human Resources
- Eric Bjerkholt, Chief Financial Officer
- Jean-Luc Girardet, Ph.D., Senior Vice President, Technical Operations
- Vinita Kumar, Senior Vice President, Quality
- Lara Longpre, Chief Development Officer
- Joanne Quan, M.D., Chief Medical Officer
- Peter Radovich, President & Chief Operating Officer
- Paul Ross, Chief Compliance Officer
- Pamela Vig, Ph.D., Chief Scientific Officer and Head of Research
- Laura Brege, Board Member
- Patrick Heron, Managing General Partner, Frazier Healthcare Partners
- Tim Walbert, Former Chairman, President and Chief Executive Officer, Horizon Therapeutics; Sr. Advisor, Amgen
- Lon Cardon, Ph.D., FMedSci., Board Member
- William C. Fairey, Board Member
- Laurent Fischer, M.D., President & Chief Executive Officer, Adverum Biotechnologies
- Mike Grey, Chairman of the Board, Mirum Pharmaceuticals
- Saira Ramasastry, MS, MPhil, Managing Partner, Life Sciences Advisory, LLC
Last updated: 2024-12-31
scPharmaceuticals Inc.
FUROSCIX
sc Pharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing pharmaceutical products, with a lead product candidate, FUROSCIX, aimed at treating congestion in heart failure patients using an on-body infusor.
About | Leadership | Contact | Contact | Careers | About | About | About | About | Careers | Careers | Careers | Careers | About | About | About
Symbol: SCPH
Recent Price: $3.50
Industry: Biotechnology
CEO: Mr. John H. Tucker
Sector: Healthcare
Employees: 135
Address: 2400 District Avenue, Burlington, MA 01803
Phone: 617 517 0730
Leadership
- John H. Tucker, President and Chief Executive Officer
- Rachael Nokes, Chief Financial Officer
- Mike Hassman, Senior Vice President, Technical Operations
- John Mohr, Pharm.D., FIDP, Senior Vice President, Clinical Development and Medical Affairs
- William T. Abraham, MD,
- Mette Kirstine Agger, Co-Founder & CEO, 7TM Pharma A/S
- Minnie V. Baylor-Henry, President, B-Henry & Associates
- Sara Bonstein, CFO, Insmed Incorporated
- Frederick Hudson, Former Partner in Charge of KPMG’s Largest Healthcare Industry Audit Practice Located in the Mid-Atlantic Region
- Jack A. Khattar, Founder, President & Chief Executive Officer, Supernus Pharmaceuticals
- Leonard D. Schaeffer, Founding Chairman & CEO, Wellpoint
- Klaus Veitinger, MD, PhD, Venture Partner, Orbimed
- Dan Bensimhon, MD, Medical Director Advanced Heart Failure & Mechanical Circulatory Support Program, Cone Health, Greensboro, NC
- G. Michael Felker, MD, Chief, Heart Failure Service, Division of Cardiology, Duke University School of Medicine
- Marv Konstam, MD, Professor of Medicine, Tufts University School of Medicine, Chief Physician Executive of the Cardiovascular Center at Tufts Medical Center
- W. Frank Peacock, MD, FACEP, FACC, FESC, Professor, Vice Chair of Research, Department of Emergency Medicine, Baylor College of Medicine, Ben Taub General Hospital
- Stuart Russell, MD, Regional Director of Heart Failure Program, Duke University School of Medicine
- James E. Udelson, MD, Chief, Division of Cardiology, Tufts Medical Center, Professor of Medicine and Radiology Tufts University School of Medicine
- William Weintraub, MD, Director of Outcomes Research, MedStar Heart and Vascular Institute
Last updated: 2024-12-31
Syros Pharmaceuticals, Inc.
Tamibarotene
Syros Pharmaceuticals is a biopharmaceutical company focused on developing treatments for cancer and monogenic diseases through gene control medicines. Key products include Tamibarotene for myelodysplastic syndrome and acute myeloid leukemia, and SY-5609 for advanced solid tumors.
About | Leadership | Directors | About | Contact | Careers | Vision/Values | DEI | Careers | About | About
Symbol: SYRS
Recent Price: $0.25
Industry: Biotechnology
CEO: Mr. Conley Chee
Sector: Healthcare
Employees: 68
Address: 35 CambridgePark Drive, Cambridge, MA 02140
Phone: 617 744 1340
Leadership
- Conley Chee, President and Chief Executive Officer
- Jason Haas, Chief Financial Officer
- Gerald E. Quirk, Chief Legal & Compliance Officer; Chief Business Officer
- Lisa Roberts, VP Human Resources
- David A. Roth, M.D., Chief Medical Officer
- Kristin Stephens, Chief Development Officer
Last updated: 2024-12-31
Vincerx Pharma, Inc.
VIP152
Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company focused on researching and developing therapies to address unmet medical needs for cancer treatment in the United States. Their lead product candidate, VIP152, is a cyclin-dependent kinase-9 inhibitor for advanced cancer.
Symbol: VINC
Recent Price: $0.33
Industry: Biotechnology
CEO: Dr. Ahmed M. Hamdy M.D.
Sector: Healthcare
Employees: 42
Address: 260 Sheridan Avenue, Palo Alto, CA 94306
Phone: 650 800 6676
Last updated: 2024-12-31
Vir Biotechnology, Inc.
Sotrovimab (VIR-7832), VIR-2218, VIR-3434, VIR-2482, VIR-1111
Vir Biotechnology, Inc. is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV.
Vision/Values | About | Leadership | About | Contact | Contact | Careers | Jobs | About | About
Symbol: VIR
Recent Price: $7.33
Industry: Biotechnology
CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Sector: Healthcare
Employees: 587
Address: 499 Illinois Street, San Francisco, CA 94158
Phone: 415 906 4324
Leadership
- Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and Director
- Jeff Calcagno, M.D., Executive Vice President and Chief Business Officer
- Vanina de Verneuil, J.D., Executive Vice President, General Counsel and Corporate Secretary
- Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head Oncology
- Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer
- Jenny Gumm, Ed.D., MBA, Executive Vice President, Chief Human Resources Officer
- Aine Hanly, Ph.D., Executive Vice President and Chief Technology Officer
- Jason O’Byrne, MBA, Executive Vice President and Chief Financial Officer
- Jennifer Eileen Towne, Ph.D., Executive Vice President and Chief Scientific Officer
- Arran Attridge, Senior Vice President Corporate Communications
- Antonio Lanzavecchia, M.D., Senior Vice President and Senior Research Fellow
- Amalio Telenti, M.D, Ph.D., Executive Vice President and Senior Research Fellow
Last updated: 2024-12-31
Aadi Bioscience, Inc.
FYARRO
Aadi Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers involving m TOR pathway gene alterations. Their lead drug candidate, FYARRO, is utilized in treating cancers with specific genomic alterations activating the m TOR pathway.
About | Contact | Contact | Contact | Careers | Careers | Jobs | About | Careers | About | About
Symbol: AADI
Recent Price: $2.96
Industry: Biotechnology
CEO: Mr. David J. Lennon Ph.D.
Sector: Healthcare
Employees: 70
Address: 17383 Sunset Boulevard, Pacific Palisades, CA 90272
Phone: 424 473 8055
Last updated: 2024-12-31
Arbutus Biopharma Corporation
AB-729, AB-836, AB-161, AB-101
Arbutus Biopharma Corporation is a biopharmaceutical company that develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses. The company's HBV product pipeline includes RNA interference products and oral capsid inhibitors, and it is involved in strategic alliances for research and development.
About | Leadership | Directors | Contact | Contact | Culture | Jobs | Culture | About | About
Symbol: ABUS
Recent Price: $3.20
Industry: Biotechnology
CEO: Mr. Michael J. McElhaugh
Sector: Healthcare
Employees: 73
Address: 701 Veterans Circle, Warminster, PA 18974
Phone: 267 469 0914
Leadership
- Michael J. McElhaugh, Interim President and Chief Executive Officer and Director
- Michael J. Sofia PhD, Chief Scientific Officer
- Karen Sims, MD, PhD, Chief Medical Officer
- David C. Hastings, Chief Financial Officer
- Christopher Naftzger, General Counsel and Chief Compliance Officer
- Lisa Caperelli, Vice President, Investor Relations
- Shannon Briscoe, SPHR, SHRM-SCP, Vice President, Human Resources
- Frank Torti, MD, Chairman
- Daniel Burgess, Independent Director
- Richard C. Henriques, Independent Director
- Keith Manchester, MD, Independent Director
- James Meyers, Independent Director
- Melissa V. Rewolinski, PhD, Independent Director
Last updated: 2024-12-31
Nuvectis Pharma, Inc.
NXP800, NXP900
Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.
Symbol: NVCT
Recent Price: $5.14
Industry: Biotechnology
CEO: Mr. Ron Bentsur M.B.A.
Sector: Healthcare
Employees: 13
Address: 1 Bridge Plaza, Fort Lee, NJ 07024
Phone: 201 614 3150
Last updated: 2024-12-31
Terns Pharmaceuticals, Inc.
TERN-101, TERN-201, TERN-501, TERN-601
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.
About | Contact | Careers | Careers | Careers | About | About | Careers | Culture | About | Leadership | About
Symbol: TERN
Recent Price: $7.15
Industry: Biotechnology
CEO: Ms. Amy L. Burroughs M.B.A.
Sector: Healthcare
Employees: 66
Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404
Phone: 650 525 5535
Last updated: 2024-11-08
Ventyx Biosciences, Inc.
VTX958
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule product candidates for the treatment of inflammatory diseases and autoimmune disorders. Key products include VTX958 for immune-mediated diseases, VTX002 for ulcerative colitis, and VTX2735 for systemic inflammatory diseases.
Symbol: VTYX
Recent Price: $2.23
Industry: Biotechnology
CEO: Dr. Raju S. Mohan Ph.D.
Sector: Healthcare
Employees: 73
Address: 662 Encinitas Boulevard, Encinitas, CA 92024
Phone: 760 593 4832
Last updated: 2024-12-31